ALNY
Alnylam Pharmaceuticals Inc.
Latest News for ALNY
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Danaher (DHR – Research Report), Nurix Therapeutics ......
In a report released today, Cory Kasimov from Evercore ISI maintained a Buy rating on Alnylam Pharma, with a price target of $515.00. According to ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alnylam Pharma (ALNY – Research Report) and Foghorn ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY – Research Report), GeneDx Ho......
Oppenheimer analyst Kostas Biliouris maintained a Buy rating on Alnylam Pharma yesterday and set a price target of $500.00. The company’s shares cl......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $339.11 | +0.3% | 1.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW